Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06QER
|
||||
Former ID |
DNC010425
|
||||
Drug Name |
Benzaldehyde O-4-(nonyloxy)phenylcarbamoyl oxime
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530604] | ||
Structure |
Download2D MOL |
||||
Formula |
C23H30N2O3
|
||||
Canonical SMILES |
CCCCCCCCCOC1=CC=C(C=C1)NC(=O)ON=CC2=CC=CC=C2
|
||||
InChI |
1S/C23H30N2O3/c1-2-3-4-5-6-7-11-18-27-22-16-14-21(15-17-22)25-23(26)28-24-19-20-12-9-8-10-13-20/h8-10,12-17,19H,2-7,11,18H2,1H3,(H,25,26)/b24-19+
|
||||
InChIKey |
GOOXRXVIMOMQCL-LYBHJNIJSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530604] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.